Davern Capital Partners, Lp Portfolio Stock Holdings

According to the SEC 13F filed on August 13, 2026, Davern Capital Partners, Lp disclosed 15 stock positions valued at approximately $586.54M as of quarter-end June 30, 2026. The largest holdings include BIONTECH SE, ROIVANT SCIENCES LTD, and ROYALTY PHARMA PLC.

Report Period
June 30, 2026
No. of Stocks
15
Portfolio Value
$586.54M
Holdings by Sector
Davern Capital Partners, Lp Portfolio Holdings in Q2 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
BIONTECH SEBNTXHealthcare11.97%754,550+449,495+147.35%$70,210,878
ROIVANT SCIENCES LTDROIVHealthcare11.66%1,932,904+1,059,506+121.31%$68,405,473
ROYALTY PHARMA PLCRPRXOther11.05%1,155,809+635,800+122.27%$64,806,211
IONIS PHARMACEUTICALS INCIONSHealthcare10.80%798,709+411,806+106.44%$63,329,637
INSMED INCINSMHealthcare10.18%559,824+377,262+206.65%$59,688,435
REGENERON PHARMACEUTICALSREGNHealthcare9.85%92,640+47,840+106.79%$57,764,746
LEGEND BIOTECH CORPLEGNHealthcare5.87%1,191,522-123,226-9.37%$34,411,155
ALNYLAM PHARMACEUTICALS INCALNYHealthcare5.80%113,085+113,085+100.00%$34,041,978
NATERA INCNTRAHealthcare5.51%118,975-24,991-17.36%$32,295,764
STRUCTURE THERAPEUTICS INCGPCRHealthcare4.08%446,059+319,598+252.72%$23,939,987
MINERALYS THERAPEUTICS INCMLYSHealthcare3.95%858,753+411,600+92.05%$23,169,156
VERA THERAPEUTICS INCVERAHealthcare3.65%498,832+498,832+100.00%$21,404,881
GENERATE BIOMEDICINES INCGENBOther2.37%824,679+232,879+39.35%$13,912,335
PROCEPT BIOROBOTICS CORPPRCTHealthcare1.79%464,920+203,720+77.99%$10,497,894
AVALO THERAPEUTICS INCAVTXHealthcare1.48%468,666+468,666+100.00%$8,660,948
Showing 15 of 15 holdings in the latest reporting period.